And according to a study that the specific inhibitor of E2-conjugating enzyme Ubc13-Uev1A could impede the progression of diffuse large B-cell lymphoma [29], further research on UBE2N inhibitors could provide an effective method to inhibit the progression of LUAD. This evidence concerns the gene UBE2N and diffuse large B-cell lymphoma.